MAXIMAL KIDNEY WIDTH BUT NOT LENGTH PREDICTS NEED FOR NEPHRECTOMY IN ADPKD PATIENTS UNDERGOING RENAL TRANSPLANTATION
ISN Academy, Sahier El Khashab, 177646
MESOAMERICAN NEPHROPATHY: CKD MORTALITY IN CHICHIGALPA, NICARAGUA BETWEEN 2002 AND 2012
ISN Academy, Dorien Faber, 177649
POTENTIAL PRESENCE OF CKD OF UNKNOWN ORIGIN (CKDu) IN THE UNITED STATES: AN ANALYSIS OF HOT SPOTS OF ESRD IN THE US
ISN Academy, Rajiv Saran, 177650
AVERAGE RATE OF DECLINE IN eGFR IS 8.8 mL/min/1.73m2 PER YEAR AMONGST APPARENTLY HEALTHY YOUNG ADULTS FROM COMMUNITIES AT RISK OF MESOAMERICAN NEPHROPATHY
ISN Academy, Marvin Antonio Gonzalez, 177651
HISTOPATHOLOGIC CHARACTERIZATION OF ACUTE MESOAMERICAN NEPHROPATHY (MeN): INSIGHTS INTO THE MECHANISM OF DISEASE
ISN Academy, Rebecca Fischer, 177653
COMPARISON OF KIDNEY BIOPSIES AND BIOCHEMICAL CHARACTERISTICS FROM PATIENTS WITH CKDu IN SRI LANKA AND CENTRAL AMERICA
ISN Academy, Julia Wijkström, 177657
AN EVIDENCE-BASED CLINICAL CASE DEFINITION OF ACUTE MESOAMERICAN NEPHROPATHY
ISN Academy, Rebecca Fischer, 177661
VALIDATION OF A SIMPLE AND ECONOMIC HPLC-UV METHOD FOR THE SIMULTANEOUS DETERMINATION OF PLASMA LEVELS OF VANCOMYCIN, MEROPENEM, PIPERACILLIN AND TAZOBACTAM IN CRITICALLY ILL PATIENTS
ISN Academy, Lilia Rizo Topete, 177675
HYPOKALEMIA AND DISTAL RENAL TUBULAR ACIDOSIS IS A FEATURE OF CKD-u IN SRI LANKA – CASE SERIES
ISN Academy, Charaka Ratnayake, 177691
RESTLESS LEGS SYNDROME AND IRON METABOLISM IN CHRONIC KIDNEY DISEASE ON HEMODIALYSIS
ISN Academy, ABDULLAH ABDULLAH, 177693
CORRELATION OF EXPRESSION OF PLASMID-MEDIATED RESISTANCE GENES WITH ANTIBIOTIC RESISTANCE DEVELOPMENT IN UROPATHOGENS CLINICALLY ISOLATED FROM CHRONIC KIDNEY DISEASE PATIENTS WITH PYELONEPHRITIS
ISN Academy, Olga Chub, 177694
MANAGEMENT OF HEPATITIS C RELATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS IN THE ERA OF DIRECT ANTIVIRAL AGENTS
ISN Academy, Ali Shendi Mohamed, 177700
INCIDENCE OF HUMAN PARVOVIRUS B19 INFECTION IN KIDNEY RECIPIENTS
ISN Academy, Milagros Flores Fonseca, 177702
INFECTIVE ENDOCARDITIS PRESENTING AS PAUCIIMMUNE VASCULITIS
ISN Academy, Mauro Braun, 177709
SPECTRUM OF IgG4 RELATED KIDNEY DISEASE AT A TERTIARY CARE CENTER IN NORTH INDIA
ISN Academy, NIDHI SINGH, 177710
TRIPLET PREGNANCY IN A DIABETIC MOTHER WITH KIDNEY TRANSPLANTATION, CASE REPORT AND REVIEW OF LITERATURE
ISN Academy, Tarek Mahmoud, 177711
POTASSIUM CHANNEL INHIBITOR IMPROVES ESTABLISHED DIABETIC NEPHROPATHY
ISN Academy, Carol Pollock, 177717
PREVALENCE OF LOW HANDGRIP STRENGTH AND ASSOCIATION WITH ANTHROPOMETRY IN HEMODILYSIS PATIENTS
ISN Academy, Ana Clara Marini, 177744
POSSIBLE PATHWAYS OF GUT MICROBIOME MODULATION BY PROBIOTICS IN CHRONIC KIDNEY DISEASE.
ISN Academy, Natarajan Ranganathan, 177751
CKD4 PERIOD PATIENTS NUTRITION STATUS AND THE RALATIONSHIP BETWEEN THE INTESTINAL MUCOSAL IMMUNE BARRIER
ISN Academy, na hao, 177752
HEALTH INSURANCE AND PERITONEAL DIALYSIS USE IN THE UNITED STATES
ISN Academy, Samaya Qureshi, 177753
THE EFFECT OF HIV INFECTION ON STAPHYLOCOCCUS AUREUS NASAL CARRIAGE AND STAPHYLOCOCCUS PERITONITIS AND CATHETER RELATED INFECTIONS AMONG PATIENTS UNDERGOING PERITONEAL DIALYSIS
ISN Academy, Kwazi Ndlovu, 177760
DOUBLE MINI PERINONEAL EQUILIBRATION TEST (mini-PET) IN EVALUATION OF PERITONEAL MEMBRANE FUNCTION AND ITS DETERMINANTS
ISN Academy, Alexander Zemchenkov, 177761
2 YEARS EXPERIENCE ON CHRONIC AMBULATORY PERITONEAL DIALYSIS (CAPD) - A DESCRIPTIVE STUDY ON CAPD AS A NOVEL RENAL REPLACEMENT MODALITY IN SRI-LANKA
ISN Academy, Charaka Ratnayake, 177768
PREVALENCE OF RISK FACTORS FOR DEVELOPMENT OF PERITONITIS RELATED TO DIALYSIS IN PATIENTS WITH CKD IN PERITONEAL DIALYSIS PROGRAM AT A MEXICAN CENTER.
ISN Academy, Viridiana Morales, 177769
SPECTRUM AND LONGITUDINAL TRENDS OF RENAL DYSFUNCTION IN TYPE 2 DIABETES WITH COEXISTENT CARDIOVASCULAR DISEASE: RELEVANCE TO MEDICATION DOSING AND TITRATIONS
ISN Academy, Urmila Anandh, 177794
CORONARY ARTERY CALCIUM [CAC] SCORES AND EARLY STAGE DIABETIC KIDNEY DISEASE [DKD]: GOOD MARKERS OF PRECLINICAL ATHEROSCLEROSIS AND NEED FOR AGGRESSIVE THERAPY IN DIABETES
ISN Academy, Urmila Anandh, 177795
POST TRANSPLANT DIABETES MELLITUS (PTDM) IN KUWAIT
ISN Academy, Tarek Mahmoud, 177803
NON-DIABETIC RENAL DISEASE (NDRD) IN TYPE 2 DIABETES MELITUS: STUDY OF RENAL – RETINAL RELATIONSHIP
ISN Academy, Jai Prakash, 177804
NEPHROSEQ: A WEB-BASED GENE EXPRESSION DATABASE AND ANALYSIS PLATFORM
ISN Academy, Rebecca Steck, 177808
Arterial hypertension after renal transplantation: prevalence and risk factors
ISN Academy, Telmoudi Aicha, 177814
ESTABLISHING RENAL SERVICES IN FIJI: AN ISN SISTER RENAL CENTRE PROGRAM
ISN Academy, Angus Ritchie, 177818
CARDIOVASCULAR OUTCOMES REPORTED IN HEMODIALYSIS TRIALS; A SYSTEMATIC REVIEW
ISN Academy, David Johnson, 177821
Drug Dosing During RRT
ISN Academy, Linda Awdishu, 178854
Metformin
ISN Academy, Marc De Broe, 178868
DPP-4 Inhibitors
ISN Academy, Per-Henrik Groop, 178869
GLP-1 Receptor Agonists
ISN Academy, Katherine Tuttle, 178870
SGLT2 Inhibitors: From Physiology to Application. Special Lecture
ISN Academy, Ernest Wright, 178872
Insulins
ISN Academy, Peter Rossing, 178871
From Biomarkers to Precision Medicine - The Big Gap
ISN Academy, Hiddo Lambers Heerspink, 178861
Use of Diet in People with Advanced CKD
ISN Academy, Adamasco Cupisti, 178813
Lesson 1: The Transplant Kidney
ISN Academy, Mark Haas, 178884
Lesson 1: Infection-Related Kidney Disease – Regional Causes
ISN Academy, Wesam Ismail, 178826
IMPACT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS ON CHRONIC KIDNEY DISEASE (CKD) PROGRESSION AND SURVIVAL IN THE RENAL HEALTHCARE PROGRAM OF URUGUAY.
ISN Academy, G Ottati, 177838
RENAL HEALTH: AN INNOVATIVE APPLICATION FOR PATIENTS WITH CHRONIC KIDNEY DISEASE
ISN Academy, Geraldo da Silva Junior, 177842
MEDICAL STUDENTS IN THE WORLD KIDNEY DAY: KNOWLEDGE AND PREVENTION EXPERIENCE IN FORTALEZA CITY, BRAZIL
ISN Academy, Geraldo da Silva Junior, 177843
PREVENTING KIDNEY DISEASE: MEDICAL STUDENTS TAKING PART IN SOCIAL ACTS IN A LARGE URBAN AREA IN BRAZIL
ISN Academy, Geraldo da Silva Junior, 177844
LOW KNOWLEDGE ABOUT CHRONIC KIDNEY DISEASE BY THE GENERAL POPULATION: A CHALLENGE FOR PREVENTION
ISN Academy, Geraldo da Silva Junior, 177845
DEPRESSIVE SYMPTOMS IN CHRONIC KIDNEY DISEASE: A COMPARATIVE STUDY AMONG PATIENTS IN HEMODIALYSIS AND CONSERVATIVE TREATMENT
ISN Academy, Geraldo da Silva Junior, 177846
COPING STRATEGIES AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY COMPARING PATIENTS RECEIVING CONSERVATIVE TREATMENT AND HEMODIALYSIS
ISN Academy, Geraldo da Silva Junior, 177847
CONSTRUCTION AND VALIDATION OF AN EDUCATIONAL TOOL FOR THE FOLLOW-UP AND PREVENTION OF COMPLICATIONS OF PATIENTS WITH CHRONIC KIDNEY DISEASE
ISN Academy, Geraldo da Silva Junior, 177848
Real-Time, Non-Invasivee eGFR Determination and Monitoring
ISN Academy, Zvi Burbea, 177874
PROGRESSION OF CHRONIC RENAL DISEASE IN A HOSPITAL OF REFERENCE OF SOCIAL SECURITY IN PERU 2012-2015
ISN Academy, Jessica Bravo Zuniga, 177875
FACILITATING VALUE-BASED RENAL CARE: THE CASE FOR CONVECTIVE THERAPIES
ISN Academy, Sudhir Bowry, 177876
AKI DEFINITION AND MANAGEMENT VARIABILITY, A NATIONAL SURVEY
ISN Academy, Mohamed Elrggal, 177884
ACUTE KIDNEY INJURY AFTER BONE MARROW TRANSPLANTATION
ISN Academy, Geraldo da Silva Junior, 177886
ARRHYTHMIAS AMONG PATIENTS WITH LEPTOSPIROSIS-ASSOCIATED ACUTE KIDNEY INJURY: A CASE SERIES IN NORTHEAST BRAZIL
ISN Academy, Geraldo da Silva Junior, 177887
THE FIRST YEAR’S EXPERIENCE OF A DEDICATED INPATIENT RENAL WARD IN MALAWI
ISN Academy, Alison Craik, 177888
NON-CRITICAL CARE HOSPITAL-ACQUIRED ACUTE KIDNEY INJURY: RISK FACTORS AND CLINICAL OUTCOMES
ISN Academy, Kateir Contreras, 177889
UPPER BODY BLOOD FLOW AND MORTALITY RISK IN HEMODIALYSIS PATIENTS
ISN Academy, Israel David Campos Gonzalez, 177916
THROMBOCYTOPENIA ASSOCIATED WITH NXSTAGE HEMODIALYSIS
ISN Academy, Órla Dunne, 177919
IMPACT OF REGULAR OR EXTENDED HD AND HDF ON PLASMA OXALATE LEVELS IN ESRD PATIENTS
ISN Academy, Theresa Ermer, 177922
LUNG ULTRASOUND AS BED SIDE TEST FOR ASSESSMENT OF LUNG CONGESTION AND PREDICTION OF ISCHEMIC HEART DISEASE IN HEMODIALYSIS PATIENTS
ISN Academy, Sahier El Khashab, 177925
ROLE OF DOPPLER ULTRASOUND IN SURVEILLANCE OF VASCULAR ACCESS IN HEMODIALYSIS PATIENTS AND DETERMINATION OF PROPER TIMING FOR RADIOLOGICAL INTERVENTION
ISN Academy, Sahier El Khashab, 177927
IMPACT OF CORRECTION OF ANEMIA IN ESRD PATIENTS ON CEREBRAL CIRCULATION AND COGNITIVE FUNCTION
ISN Academy, Sahier El Khashab, 177933
PREGNANCY OUTCOMES IN END STAGE KIDNEY DISEASE PATIENTS AT CHO RAY HOSPITAL
ISN Academy, Thi Ngoc Thu Du, 177941
EARLY REFERRAL INCREASES PRE-EMPTIVE KIDNEY TRANSPLANT (PKT)
ISN Academy, Aklilu Yishak, 177948
REASSESSING CREATININE AS A MARKER OF NEONATAL ACUTE KIDNEY INJURY: INSIGHTS FROM THE ASSESSMENT OF WORLDWIDE ACUTE KIDNEY INJURY EPIDEMIOLOGY IN NEONATES (AWAKEN) COHORT
ISN Academy, Carolyn Abitbol, 178805
The Rising Burden of Type 2 Diabetes In Youth
ISN Academy, Dana Dabelea, 178806
Risk of Diabetes in Children with CKD: From Genetics to Environment
ISN Academy, Michel Tsimaratos, 178807
Diabetic Kidney Disease in the Pima Indians - Novelty or Harbinger?
ISN Academy, Robert Nelson, 178808
The Impact of Diabetes on Prognosis in People with Stage 4CKD
ISN Academy, Brenda Hemmelgarn, 178811
Management of Non-Renal Diabetic Complications in People with Advanced CKD
ISN Academy, Merlin Thomas, 178814
Transplantation
ISN Academy, Jeremy Chapman, 178816
Epigenetics in Kidney Disease Progression
ISN Academy, Katalin Susztak, 178831
Proteomic Data Base of CKD for Biomarker and Molecular Target Discovery
ISN Academy, antonia vlahou, 178832
Introduction of the Roscoe R. Robinson Award. Presentation of the award to Mignon McCulloch (South Africa)
ISN Academy, John Feehally, 178834
Introduction of the ‘Claude Amiel Lecture’ and Mark Pepys (UK)
ISN Academy, Pierre Ronco, 178836
Claude Amiel Lecture - Therapeutic Progress in Amyloidosis
ISN Academy, Mark Pepys, 178837
Introducing ISN Research Portfolio: Objectives, Networks, Programs and Integration
ISN Academy, Marcello Tonelli, 178838
What Is ISN-ACT
ISN Academy, Vlado Perkovic, 178839
How to Design Better Trials
ISN Academy, Dick de Zeeuw, 178840
Dosing RRT In AKI: Challenges and Opportunities
ISN Academy, Rolando Claure-Del Granado, 178852
PD For AKI: A Viable Option?
ISN Academy, Daniela Ponce, 178853
Saving Young Lives- Have We Succeeded?
ISN Academy, Mignon McColluch, 178855
MICRONUTRIENT LOSS IN RENAL REPLACEMENT THERAPY FOR ACUTE KIDNEY INJURY
ISN Academy, David Gardner, 178857
How Recent Clinical Trials in Nephrology Should Change Practice Now
ISN Academy, Vlado Perkovic, 178858
Lessons Learned from DKD Trials
ISN Academy, Mark E. Cooper, 178859
Streamlining Clinical Trials to Enhance Feasibility
ISN Academy, David Wheeler, 178860
Conducting Clinical Trials in Low and Middle Income Countries
ISN Academy, Hong Zhang, 178862
Patient Priorities in Clinical Research
ISN Academy, Fiona Loud, 178863
INFLUENCE OF FLUID REMOVAL DURING HEMODIALYSIS ON HEMODYNAMIC PARAMETERS
ISN Academy, Nathan Levin, 178878
IMPACT OF REGULAR OR EXTENDED HD AND HDF ON PLASMA OXALATE LEVELS IN ESRD PATIENTS
ISN Academy, Theresa Ermer, 178879
DISPLACER-ENHANCED DIALYTIC REMOVAL OF PROTEIN-BOUND UREMIC TOXINS DURING HEMODIALYSIS
ISN Academy, Magdalena Madero, 178880
Designing a Randomised Clinical Trial
ISN Academy, Dick de Zeeuw, 178881
Understanding Risk Scores: How to Interpret, What Do They Add?
ISN Academy, Meg Jardine, 178882
Test Performance. How to Evaluate if a Test Is Useful (incl. STARD Statement)
ISN Academy, Germaine Wong, 178883
Interactive Kidney Biopsy Cases
ISN Academy, Werner de León, 178888
Interactive Kidney Biopsy Cases
ISN Academy, Paisit Paueksakon, 178889
Genetic Adaptation to High Altitude. Special Lecture
ISN Academy, Abigail Bigham, 178890

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings